Zobrazeno 1 - 10 of 407 pro vyhledávání: '"Kari K. Alitalo"'
7
Genetic Variants of
Autor: Daniel J, Crona, Andrew D, Skol, Veli-Matti, Leppänen, Dylan M, Glubb, Amy S, Etheridge, Eleanor, Hilliard, Carol E, Peña, Yuri K, Peterson, Nancy, Klauber-DeMore, Kari K, Alitalo, Federico, Innocenti
Publikováno v: Cancer research. 79(1)
Molecular markers of sorafenib efficacy in metastatic renal cell carcinoma (mRCC) patients are not available. The purpose of this study was to discover genetic markers of survival in mRCC patients treated with sorafenib. Germline variants from 56 gen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3d3d7b8db376498009038652d349b6b2
https://pubmed.ncbi.nlm.nih.gov/30385613
Zobrazit plný text záznamu
8
Akademický článek
Multi-omics characterization of lymphedema-induced adipose tissue resulting from breast cancer-related surgery.
Autor: Karaman S; Wihuri Research Institute, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Lehti S; Wihuri Research Institute, Helsinki, Finland.; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland., Zhang C; Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden., Taskinen MR; Research Programs Unit, Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland., Käkelä R; Helsinki University Lipidomics Unit (HiLIPID), Helsinki Institute of Life Science (HiLIFE) and Biocenter Finland, Helsinki, Finland.; Molecular and Integrative Biosciences Research Program, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland., Mardinoglu A; Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK., Brorson H; Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden.; Plastic and Reconstructive Surgery, Skåne University Hospital, Malmö, Sweden.; Lund University Cancer Centre, Lund, Sweden.; Department of Health Sciences, Faculty of Medicine, Health & Human Sciences, Macquarie University, Sydney, New South Wales, Australia., Alitalo K; Wihuri Research Institute, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kivelä R; Wihuri Research Institute, Helsinki, Finland.; Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.; Stem Cell and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Oct 31; Vol. 38 (20), pp. e70097.
Zobrazit plný text záznamu
9
Akademický článek
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.
Autor: Roos-Mattila M; Department of Surgery, Helsinki University Hospital, Helsinki, Finland. matilda.roos-mattila@helsinki.fi.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. matilda.roos-mattila@helsinki.fi.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland. matilda.roos-mattila@helsinki.fi., Kallio P; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Luck TJ; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Polso M; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Kumari R; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Mikkonen P; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Välimäki K; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Malmstedt M; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Ellonen P; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Pellinen T; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Heckman CA; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Mustonen H; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Puolakkainen PA; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland., Alitalo K; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Wihuri Research Institute, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Kallioniemi O; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland.; Science for Life Laboratory (SciLifeLab), Department of Oncology and Pathology, Karolinska Institutet, Solna, 17165, Sweden., Mirtti T; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Rannikko AS; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; ONCOSYS Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Pietiäinen VM; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.; Institute for Molecular Medicine Finland -FIMM, Helsinki Institute for Life Sciences -HiLIFE, University of Helsinki, Helsinki, Finland., Seppänen HE; Department of Surgery, Helsinki University Hospital, Helsinki, Finland.; Translational Cancer Medicine Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
Publikováno v: Communications biology [Commun Biol] 2024 Oct 20; Vol. 7 (1), pp. 1355. Date of Electronic Publication: 2024 Oct 20.
Zobrazit plný text záznamu
10
Akademický článek
The Impact of VEGF-C-Induced Dural Lymphatic Vessel Growth on Ischemic Stroke Pathology.
Autor: Keuters MH; Neuroscience Center, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00014, Helsinki, Finland.; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland., Antila S; Wihuri Research Institute and Translational Cancer Medicine Program, University of Helsinki, 00014, Helsinki, Finland., Immonen R; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland., Plotnikova L; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland., Wojciechowski S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland., Lehtonen S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland., Alitalo K; Wihuri Research Institute and Translational Cancer Medicine Program, University of Helsinki, 00014, Helsinki, Finland., Koistinaho J; Neuroscience Center, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00014, Helsinki, Finland.; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland.; Drug Research Program, Division of Pharmacology and Pharmacotherapy, University of Helsinki, 00014, Helsinki, Finland., Dhungana H; Neuroscience Center, Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00014, Helsinki, Finland. hiramani.dhungana@helsinki.fi.; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210, Kuopio, Finland. hiramani.dhungana@helsinki.fi.
Publikováno v: Translational stroke research [Transl Stroke Res] 2024 Jun 01. Date of Electronic Publication: 2024 Jun 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje